Caption Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-82,000
| Closed | -$920K | – | 796 |
|
|
2022
Q4 | $920K | Buy |
82,000
+22,000
| +37% | +$247K | 0.01% | 150 |
|
|
2022
Q3 | $608K | Buy |
+60,000
| New | +$608K | 0.01% | 199 |
|
|
2022
Q2 | – | Sell |
-31,800
| Closed | -$304K | – | 886 |
|
|
2022
Q1 | $304K | Buy |
+31,800
| New | +$304K | ﹤0.01% | 359 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 903 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 788 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 735 |
|
|
2020
Q4 | – | Sell |
-4,400
| Closed | -$65K | – | 629 |
|
|
2020
Q3 | $65K | Sell |
4,400
-2,017
| -31% | -$29.8K | ﹤0.01% | 313 |
|
|
2020
Q2 | $135K | Buy |
+6,417
| New | +$135K | ﹤0.01% | 241 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 560 |
|
|
2019
Q3 | – | Sell |
-80,000
| Closed | -$1.31M | – | 470 |
|
|
2019
Q2 | $1.31M | Buy |
80,000
+67,500
| +540% | +$1.1M | 0.07% | 67 |
|
|
2019
Q1 | $284K | Buy |
+12,500
| New | +$284K | 0.02% | 152 |
|